1. Home
  2. Labeler Index
  3. Allergan, Inc.
  4. 0430-3754
  5. Product Images: Estrace

Product Images Estrace

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Estrace NDC 0430-3754 by Allergan, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The structural formula for ESTRACE (estradiol vaginal cream, USP, 0.01%) contains 0.1 mg estradiol in a nonliquefying base containing purified water, propylene glycol, stearyl alcohol, white ceresin wax, mono- and di-glycerides, hypromellose 2208 (4000 cps), sodium lauryl sulfate, methylparaben, edetate di-sodium and tertiary-butylhydroquinone. Estradiol is chemically described as estra-1,3,5(10)-triene-3, 17(beta)-diol. It has an empirical formula of C18H24O2 and molecular weight of 272.37. - estrace cream 01

The structural formula for ESTRACE (estradiol vaginal cream, USP, 0.01%) contains 0.1 mg estradiol in a nonliquefying base containing purified water, propylene glycol, stearyl alcohol, white ceresin wax, mono- and di-glycerides, hypromellose 2208 (4000 cps), sodium lauryl sulfate, methylparaben, edetate di-sodium and tertiary-butylhydroquinone. Estradiol is chemically described as estra-1,3,5(10)-triene-3, 17(beta)-diol. It has an empirical formula of C18H24O2 and molecular weight of 272.37. - estrace cream 01

TABLE 2 -Relative and Absolute Risk Seen in the Estrogen Plus Progestin Substudy of WHI at an Average of 5.6 Years a,b - estrace cream 02

TABLE 2 -Relative and Absolute Risk Seen in the Estrogen Plus Progestin Substudy of WHI at an Average of 5.6 Years a,b - estrace cream 02

The text describes the results of various studies and the associated risks for different medical conditions such as non-fatal MI, ischemic stroke, endometrial cancer, hip fracture, and overall mortality. The results are based on centrally adjudicated data, and the text indicates which conditions are not included in the global index. Confidence intervals are not adjusted for il looks and multiple comparisons. Information on the source publications can be viewed at www.nhibi.nih.gov/whi.*

PRINCIPAL DISPLAY PANELNDC 0430-3754-14ESTRACE CREAM(estradiol vaginal cream, USP, 0.01%)Rx OnlyNET WT 1 ½ OZ (42.5 G) - estrace cream 03

PRINCIPAL DISPLAY PANELNDC 0430-3754-14ESTRACE CREAM(estradiol vaginal cream, USP, 0.01%)Rx OnlyNET WT 1 ½ OZ (42.5 G) - estrace cream 03

estrace cream 04

estrace cream 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.